Knack Packaging logo

Knack Packaging MD and chairman

NSE: KNACKBSE: 544814Industrial Products

Knack Packaging Limited · Face value ₹10 · Listed Jul 2026 · Issue price ₹170
Last close ₹186.04down ₹6.91 (3.58%)BSE ₹185.75

Share price at the NSE close on 30 Oct 2026. Previous close ₹192.95.

30 Oct: open ₹192.95, high ₹193.10, low ₹185.20

Range of traded prices from listing on 8 Jul 2026 to 30 Oct 2026
₹171.10Low, 16 Sep 2026₹222.00High, 10 Aug 2026
Market cap
₹2,276 Cr
P/E
No full year
P/B
3.15
Dividend yield
Nonesince listing in Jul 2026
Debt to equity
0.26
Volume, NSE
3,63,85160.5% delivered

Knack Packaging's chairperson and managing director is ALPESH TULSIBHAI PATEL, as filed for the quarter to Sep 2026.

Knack Packaging board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.

  • Chairperson and managing directorALPESH TULSIBHAI PATEL
  • Company Secretary and Compliance OfficerRavikumar Ramnarayan Pasi

6 directors3 independent3 executive

  • ALPESH TULSIBHAI PATEL · Chairperson and managing directorExecutive · joined Mar 2013 · reappointed Jul 2025 · 1 listed board · 1 committee seat
  • PRAVINKUMAR AMBALAL PATELExecutive · joined Mar 2013 · reappointed Jul 2025 · 1 listed board · 1 committee seat
  • RASHMINBHAI TULSIBHAI PATELExecutive · joined Mar 2013 · reappointed Jul 2025 · 1 listed board · 1 committee seat
  • RAJNISH MAGANIndependent · joined Jul 2025 · 15 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • DEEPTI SHARMAIndependent · joined Jul 2025 · 15 months as independent · 3 listed boards · 3 as independent · 3 committee seats, 2 as chair
  • VITTALADEVINI S BALAJIIndependent · joined Jul 2025 · 15 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 5 Sep 20266 of 6 present3 independent · 26 days in between
    • 9 Aug 20265 of 6 present3 independent · 24 days in between
    • 15 Jul 20266 of 6 present3 independent · 9 days in between
    • 5 Jul 20266 of 6 present3 independent · 11 days in between
    4 earlier meetings
    • 23 Jun 20266 of 6 present3 independent · 8 days in between
    • 14 Jun 20266 of 6 present3 independent · 2 days in between
    • 11 Jun 20266 of 6 present3 independent · 25 days in between
    • 16 May 20266 of 6 present3 independent
  • Audit Committee

    Chair RAJNISH MAGAN

    DEEPTI SHARMA, PRAVINKUMAR AMBALAL PATEL

    • 5 Sep 20263 of 3 present2 independent · 26 days in between
    • 9 Aug 20263 of 3 present2 independent · 55 days in between
    • 14 Jun 20263 of 3 present2 independent · 2 days in between
    • 11 Jun 20263 of 3 present2 independent
  • Nomination and remuneration committee

    Chair RAJNISH MAGAN

    VITTALADEVINI S BALAJI, DEEPTI SHARMA

    • 5 Sep 20263 of 3 present3 independent · 26 days in between
    • 9 Aug 20263 of 3 present3 independent
  • Stakeholders Relationship Committee

    Chair VITTALADEVINI S BALAJI

    ALPESH TULSIBHAI PATEL, RASHMINBHAI TULSIBHAI PATEL

    • 5 Sep 20263 of 3 present1 independent
  • Risk Management Committee

    Chair DEEPTI SHARMA

    RASHMINBHAI TULSIBHAI PATEL, RAJNISH MAGAN, AJAY KUMAR DUBEY

    • 5 Sep 20264 of 4 present2 independent
  • Corporate Social Responsibility Committee

    Chair VITTALADEVINI S BALAJI

    RAJNISH MAGAN, ALPESH TULSIBHAI PATEL, PRAVINKUMAR AMBALAL PATEL

    • 5 Sep 20263 of 3 present2 independent · 85 days in between
    • 11 Jun 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Sep 2026.

  • Talati & Talati LLPPeer-review certificate valid to Sep 2029

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved
00Jun 2600Sep 26

Open at the quarter's end

0Jun 260Sep 26
None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
No
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Sep 2026.

RaisedAmount raisedForSet asideSpentSpent elsewhereReason and comments
Public IssuesJul 2026, checked by CARE RATINGS LIMITED380.00Partial funding of capital expenditure towards setting up of new manufacturing facility at Borisana situated at Kadi, Mehsana, Gujarat320.000.70NoAudit committee: Audit Committee reviewed and noted that there is no deviation or variation in the utilization of IPO proceeds from the objects stated in the Prospectus
Public IssuesJul 2026, checked by CARE RATINGS LIMITED380.00General corporate Purposes31.1529.47NoAudit committee: Audit Committee reviewed and noted that there is no deviation or variation in the utilization of IPO proceeds from the objects stated in the Prospectus
Public IssuesJul 2026, checked by CARE RATINGS LIMITED380.00Issue expenses31.1525.90NoAudit committee: Audit Committee reviewed and noted that there is no deviation or variation in the utilization of IPO proceeds from the objects stated in the Prospectus
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.